Cortecs gets liver by-pass patent:
This article was originally published in Clinica
Executive Summary
Cortecs (UK) has obtained US and European patents for Halo, its liver by-pass system. The delivery system is designed to enhance the performance of drugs, especially those that are susceptible to first pass metabolism in the liver. A South African patent was granted earlier this year and the company says it is pursuing protection in other territories.